雑誌文献を検索します。書籍を検索する際には「書籍検索」を選択してください。

検索

書誌情報 詳細検索 by 医中誌

Japanese

A post-marketing surveillance of 0.5% levofloxacin ophthalmic solution for external ocular infections Yoshiko Kanda 1 , Tomoko Kayama 1 , Shinji Okamoto 1 , Masako Hashimoto 1 , Chiemi Ishida 2 , Tomoko Yanai 2 , Mitsuru Fukumoto 2 , Eiichi Kunihiro 1 1PMS Group,Santen Pharmaceutical Co Ltd 2Drug Safety Information Group,Santen Pharmaceutical Co Ltd pp.2007-2017
Published Date 2008/12/15
DOI https://doi.org/10.11477/mf.1410102568
  • Abstract
  • Look Inside
  • Reference

Abstract. Purpose:To report the safety and efficacy of 0.5% levofloxacin ophthalmic solution(Cravit® ophthalmic solution 0.5%)based on survey of institutions. Cases and Method:Report charts were obtained from ophthalmic institutions regarding patients who were treated by Cravit® ophthalmic solution 0.5% for the first time. The charts showed the patients' background,dosis,duration,adverse events,and bacteriological findings. The surveillance was conducted on three periods ranging from 2000 to 2004. Results:A total of 808 institutions supplied data on 6,760 cases. Adverse drug reactions(ADRs)occurred in 42 out of 6,686 cases(0.63%),including blepharitis 7 cases and eye irritation 6 cases. All ADRs were not serious cases throughout the study. Treatment was effective in 5,660 out of 5,929 cases(95.5%). There was no siginificant chronological shift in the rate of efficacy during the period of survey. Conclusion:Levofloxacin ophthalmic solution is safe and effective in actual use. It promises to be useful in the treatment of external eye infections.


Copyright © 2008, Igaku-Shoin Ltd. All rights reserved.

基本情報

電子版ISSN 1882-1308 印刷版ISSN 0370-5579 医学書院

関連文献

もっと見る

文献を共有